TKI258 for Metastatic Inflammatory Breast Cancer Patients
Status:
Completed
Trial end date:
2015-11-25
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if dovitinib can help to control
inflammatory breast cancer. The safety of this drug will also be studied.